These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

652 related items for PubMed ID: 10739756

  • 1. BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer.
    Moslehi R, Chu W, Karlan B, Fishman D, Risch H, Fields A, Smotkin D, Ben-David Y, Rosenblatt J, Russo D, Schwartz P, Tung N, Warner E, Rosen B, Friedman J, Brunet JS, Narod SA.
    Am J Hum Genet; 2000 Apr; 66(4):1259-72. PubMed ID: 10739756
    [Abstract] [Full Text] [Related]

  • 2. Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families.
    Levy-Lahad E, Catane R, Eisenberg S, Kaufman B, Hornreich G, Lishinsky E, Shohat M, Weber BL, Beller U, Lahad A, Halle D.
    Am J Hum Genet; 1997 May; 60(5):1059-67. PubMed ID: 9150153
    [Abstract] [Full Text] [Related]

  • 3. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2.
    Roa BB, Boyd AA, Volcik K, Richards CS.
    Nat Genet; 1996 Oct; 14(2):185-7. PubMed ID: 8841191
    [Abstract] [Full Text] [Related]

  • 4. Risk factors for detecting germline BRCA1 and BRCA2 founder mutations in Ashkenazi Jewish women with breast or ovarian cancer.
    Hodgson SV, Heap E, Cameron J, Ellis D, Mathew CG, Eeles RA, Solomon E, Lewis CM.
    J Med Genet; 1999 May; 36(5):369-73. PubMed ID: 10353781
    [Abstract] [Full Text] [Related]

  • 5. The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women.
    Abeliovich D, Kaduri L, Lerer I, Weinberg N, Amir G, Sagi M, Zlotogora J, Heching N, Peretz T.
    Am J Hum Genet; 1997 Mar; 60(3):505-14. PubMed ID: 9042909
    [Abstract] [Full Text] [Related]

  • 6. The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews.
    Hartge P, Struewing JP, Wacholder S, Brody LC, Tucker MA.
    Am J Hum Genet; 1999 Apr; 64(4):963-70. PubMed ID: 10090881
    [Abstract] [Full Text] [Related]

  • 7. Mutational analyses of BRCA1 and BRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancer.
    Shiri-Sverdlov R, Oefner P, Green L, Baruch RG, Wagner T, Kruglikova A, Haitchick S, Hofstra RM, Papa MZ, Mulder I, Rizel S, Bar Sade RB, Dagan E, Abdeen Z, Goldman B, Friedman E.
    Hum Mutat; 2000 Dec; 16(6):491-501. PubMed ID: 11102978
    [Abstract] [Full Text] [Related]

  • 8. Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
    Satagopan JM, Boyd J, Kauff ND, Robson M, Scheuer L, Narod S, Offit K.
    Clin Cancer Res; 2002 Dec; 8(12):3776-81. PubMed ID: 12473589
    [Abstract] [Full Text] [Related]

  • 9. The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%.
    Oddoux C, Struewing JP, Clayton CM, Neuhausen S, Brody LC, Kaback M, Haas B, Norton L, Borgen P, Jhanwar S, Goldgar D, Ostrer H, Offit K.
    Nat Genet; 1996 Oct; 14(2):188-90. PubMed ID: 8841192
    [Abstract] [Full Text] [Related]

  • 10. Founder BRCA 1 and 2 mutations among a consecutive series of Ashkenazi Jewish ovarian cancer patients.
    Tobias DH, Eng C, McCurdy LD, Kalir T, Mandelli J, Dottino PR, Cohen CJ.
    Gynecol Oncol; 2000 Aug; 78(2):148-51. PubMed ID: 10926794
    [Abstract] [Full Text] [Related]

  • 11. Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients.
    Fodor FH, Weston A, Bleiweiss IJ, McCurdy LD, Walsh MM, Tartter PI, Brower ST, Eng CM.
    Am J Hum Genet; 1998 Jul; 63(1):45-51. PubMed ID: 9634504
    [Abstract] [Full Text] [Related]

  • 12. The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel.
    Vazina A, Baniel J, Yaacobi Y, Shtriker A, Engelstein D, Leibovitz I, Zehavi M, Sidi AA, Ramon Y, Tischler T, Livne PM, Friedman E.
    Br J Cancer; 2000 Aug; 83(4):463-6. PubMed ID: 10945492
    [Abstract] [Full Text] [Related]

  • 13. A population-based study of BRCA1 and BRCA2 mutations in Jewish women with epithelial ovarian cancer.
    Lu KH, Cramer DW, Muto MG, Li EY, Niloff J, Mok SC.
    Obstet Gynecol; 1999 Jan; 93(1):34-7. PubMed ID: 9916952
    [Abstract] [Full Text] [Related]

  • 14. An evaluation of common breast cancer gene mutations in a population of Ashkenazi Jews.
    Lalloo F, Cochrane S, Bulman B, Varley J, Elles R, Howell A, Evans DG.
    J Med Genet; 1998 Jan; 35(1):10-2. PubMed ID: 9475087
    [Abstract] [Full Text] [Related]

  • 15. Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families.
    Cierniková S, Tomka M, Kovác M, Stevurková V, Zajac V.
    Neoplasma; 2006 Jan; 53(2):97-102. PubMed ID: 16575464
    [Abstract] [Full Text] [Related]

  • 16. Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer.
    Neuhausen S, Gilewski T, Norton L, Tran T, McGuire P, Swensen J, Hampel H, Borgen P, Brown K, Skolnick M, Shattuck-Eidens D, Jhanwar S, Goldgar D, Offit K.
    Nat Genet; 1996 May; 13(1):126-8. PubMed ID: 8673092
    [Abstract] [Full Text] [Related]

  • 17. Genetic Predisposition to Breast Cancer Due to Mutations Other Than BRCA1 and BRCA2 Founder Alleles Among Ashkenazi Jewish Women.
    Walsh T, Mandell JB, Norquist BM, Casadei S, Gulsuner S, Lee MK, King MC.
    JAMA Oncol; 2017 Dec 01; 3(12):1647-1653. PubMed ID: 28727877
    [Abstract] [Full Text] [Related]

  • 18. The founder mutations in the BRCA1, BRCA2, and ATM genes in Moroccan Jewish women with breast cancer.
    Kreiss Y, Barak F, Baruch RG, Levy-Lahad E, Pras E, Friedman E.
    Genet Test; 2000 Dec 01; 4(4):403-7. PubMed ID: 11216667
    [Abstract] [Full Text] [Related]

  • 19. Patients with double primary tumors in the breast and ovary- clinical characteristics and BRCA1-2 mutations status.
    Fishman A, Dekel E, Chetrit A, Lerner-Geva L, Bar-Am A, Beck D, Beller U, Ben-Baruch G, Piura B, Friedman E, Struewing JP, Modan B.
    Gynecol Oncol; 2000 Oct 01; 79(1):74-8. PubMed ID: 11006035
    [Abstract] [Full Text] [Related]

  • 20. BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and ovarian cancer.
    Schubert EL, Mefford HC, Dann JL, Argonza RH, Hull J, King MC.
    Genet Test; 1997 Oct 01; 1(1):41-6. PubMed ID: 10464624
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.